Speakers:

Sascha Mielcarek, CEO

Sebastian Pötzsch, CFO

Arne Wilkens, CCO

Silvia von Pistor, CIO

Discussion Points

• Company’s expansion plans and performance

• Supply chain and RTM capabilities

• Overall German MMJ market outlook

• Plans to expand in the reimbursed segment

• Partnerships with pharma companies for novel products

• Upcoming capital raise • Plans outside Germany

About Canify

Canify Ag is a licensed pharmaceutical company focusing on medical cannabis. Products based on the latest research, sophisticated manufacturing technologies, and comprehensive control processes from production to practical use of cannabis – They believe that every person deserves high-quality care, individually and specifically tailored to their own needs. Their approach to sales and distribution is to make the Canna-Biz as easy and convenient as possible for pharmacies and wholesalers. They also offer tailor-made manufacturing and market access solutions for 3rd party collaborators, setting standards in terms of quality, production capacity and delivery time. Their manufacturing excellence meets the highest standards set by European GACP and GMP guidelines, so they can deliver transparency and traceability from the grow room to the patient.

#cannabisstocks #cannabisdispensary #globalcannabis #germanycannabis #cannabislegalization #canify